Tuesday, April 11, 2006

Intellectual Capital Report

Leif Edvinsson, CEO, Universal Networking Intellectual Capital, is a speaker in the Knowledge Stream about Life Sciences at the Summit for the Future, May 3-5, 2006

Member of the project team 'Intellectual Capital Report 2004' by the Center for Molecular Medicine, CMM.

Excerpts from the report:
"Research is driven by a need for knowledge. The CMM knowledge goals are formed by society, science and various interest groups with the common aspiration to improve public health. In order to reach the knowledge goals, human, structural, and relational capital is invested in the key processes of CMM - research and knowledge transfer.

In turn, research and knowledge transfer generate results with various time-frames. Short-term results, output, are easily measured such as published discoveries or graduates from research training. These give rise to mid-term results, or outcome, when new medical treatments or science-based companies are developed. Most important, but also most difficult to measure, are
the long-term effects - the impact of the research and knowledge transfer on the public health.

The CMM Intellectual Capital Report is modelled after all these external and internal factors, capitals and results. [...]"

"Our research efforts build on four interdependent knowledge goals. The end goal is to improve quality of life. The means to meet this goal are to increase knowledge on common diseases, which in turn depends on the ability to strengthen the organizational knowledge and coaching for the future. These knowledge goals guide our daily activities as well as our long-term strategies.

1. Strengthening the organizational knowledge
The organizational knowledge base is not the sum of all facts. Sharing knowledge, networking and collaborating, form knowledge synergies which give rise to truly innovative ideas. Therefore, CMM strives to stimulate the mutual benefit between clinical experience and experimental competence, and aims to disseminate knowledge on medical technology and methodology relevant for molecular medicine. These measures strengthen the organizational knowledge base and increase the possibilities for major breakthroughs.

2. Coaching for the future
All experts have been beginners. To secure future generations of researchers in molecular medicine, we need to recruit young outstanding researchers and support their development. Our strategy is therefore to emphasize the intellectual, relational, and structural infrastructure for this group in particular.

3. Increasing knowledge on common diseases
The knowledge on common diseases is best developed through front line research. CMM is consequently aiming for competitive research and innovations, on the national as well as the international scene. Our joint efforts will successively reveal new potentials for better preemptive methods, diagnostics, and treatments.

4. Improving quality of life
The three previous objectives all aim at improving quality of life. With new knowledge, physicians can perform more accurate diagnoses and offer improved treatments. With increased awareness, all of us can choose a healthy life style and make conscious decisions about risk factors in our daily life."


This report is available as a *.pdf: click here


Post a Comment

<< Home